David Ha
Impact in
-
- Antibiotic Use and Resistance
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Epidemiology 11
- Pneumonia and Respiratory Infections 3
-
- Antibiotic Use and Resistance 11
- Co-authors
- Daniel Gluckstein (4 shared papers)Nina M. Haste (1 shared paper)Salisa C. Westrick (9 shared papers)Marisa Holubar (12 shared papers)Lina Meng (5 shared papers)Emily Mui (9 shared papers)Stan Deresinski (5 shared papers)Christopher D Stave (1 shared paper)
- Journals
- Open Forum Infectious Diseases (13 papers)Journal of the American Pharmacists Association (3 papers)Research in Social and Administrative Pharmacy (3 papers)Vaccine (2 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- United StatesVietnamSaudi Arabia
In The Last Decade
David Ha
34 papers receiving 298 citations
Peers
Comparison fields: 5 of 57
- Applied Microbiology and Biotechnology 91
- Geriatrics and Gerontology 25
- Molecular Medicine 30
- Clinical Biochemistry 30
- Health 28
Countries citing papers authored by David Ha
This map shows the geographic impact of David Ha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ha more than expected).
Fields of papers citing papers by David Ha
This network shows the impact of papers produced by David Ha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ha. The network helps show where David Ha may publish in the future.
Co-authors
The 25 scholars most cited alongside David Ha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 54 | |
| 2 | 2017 | 51 | |
| 3 | 2017 | 34 | |
| 4 | 2019 | 30 | |
| 5 | 2023 | 23 | |
| 6 | 2021 | 16 | |
| 7 | 2021 | 12 | |
| 8 | 2022 | 12 | |
| 9 | 2019 | 10 | |
| 10 | 2019 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2025 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2019 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2025 | 2 |
About David Ha
David Ha is a scholar working on Epidemiology, Applied Microbiology and Biotechnology, Infectious Diseases, Pharmacology and General Health Professions, having authored 36 papers that have together received 314 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (11 papers), Bacterial Identification and Susceptibility Testing (4 papers), Patient Satisfaction in Healthcare (3 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Vaccine Coverage and Hesitancy (3 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (91 citations), Geriatrics and Gerontology (25 citations), Molecular Medicine (30 citations), Clinical Biochemistry (30 citations) and Health (28 citations). David Ha has collaborated with scholars based in United States, Vietnam and Saudi Arabia. Frequent co-authors include Daniel Gluckstein, Nina M. Haste, Salisa C. Westrick, Marisa Holubar, Lina Meng, Emily Mui, Stan Deresinski, Christopher D Stave, Kimberly B. Garza and Mark Bounthavong. Their work appears in journals such as Open Forum Infectious Diseases, Journal of the American Pharmacists Association, Research in Social and Administrative Pharmacy, Vaccine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.